Drug Shortage Report for JAMP-LEVETIRACETAM

Last updated on 2019-07-08 History
Report ID 64233
Drug Identification Number 02403005
Brand name JAMP-LEVETIRACETAM
Common or Proper name Levetiracetam
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) LEVETIRACETAM
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 120
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-10-12
Estimated end date
Actual end date 2019-07-01
Shortage status Resolved
Updated date 2019-07-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2019-07-08 French Compare
v12 2019-07-08 English Compare
v11 2019-04-18 French Compare
v10 2019-04-18 English Compare
v9 2019-03-01 French Compare
v8 2019-03-01 English Compare
v7 2018-12-19 French Compare
v6 2018-12-19 English Compare
v5 2018-10-15 French Compare
v4 2018-10-15 English Compare
v3 2018-10-15 French Compare
v2 2018-10-15 English Compare
v1 2018-10-15 English Compare

Showing 1 to 13 of 13